ANDREA LATTA: Open Payments
NPI 1396732152 · SAINT PETERS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 37 payments from 15 companies in 2025. Trend: 2023 $665 · 2024 $817 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $134 |
| Vantive US Healthcare LLC | 1 | $117 |
| Novo Nordisk Inc | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Calliditas Therapeutics US Inc. | 2 | $80 |
| Travere Therapeutics, Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Amgen Inc. | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
Products named: SYMPLICITY G3, Renal - PD, FARXIGA, Ozempic, TARPEYO, JYNARQUE, Vanrafia, JARDIANCE.
Industry payments across MO — which companies pay providers there.
